|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 50.9 TWD | -0.97% |
|
+0.99% | -12.69% |
Li Kang Biomedical Co., Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was TWD 155.84 million compared to TWD 101.33 million a year ago. Net income was TWD 28.15 million compared to TWD 13.94 million a year ago.
Basic earnings per share from continuing operations was TWD 1.0522 compared to TWD 0.5217 a year ago. Diluted earnings per share from continuing operations was TWD 1.0435 compared to TWD 0.5217 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -12.69% | 50.55M | |
| +4.94% | 7.74B | |
| +2.93% | 5.92B | |
| -5.09% | 3.77B | |
| -11.51% | 3.52B | |
| -12.06% | 1.23B | |
| -30.37% | 1.04B | |
| +15.98% | 988M | |
| -8.94% | 929M | |
| -14.21% | 823M |
LI KANG BIOMEDICAL CO., LTD. 
